Bond.az White LogoBond.az Black Logo

UBS Downgrades Verra Mobility on Avis Loss

UBS downgrades Verra Mobility after Avis contract termination, slashing price target to $4. Stock down 71% in a week.

Olivia Taylor
ByOlivia Taylor- Senior Editor
|
0

UBS downgraded Verra Mobility (NASDAQ:VRRM) from Buy to Neutral and cut its price target to $4.00 from $23.00 after the termination of the contract with Avis Budget. The stock now trades at $3.85, down 71% over the past week and 82% over six months.

The contract loss is expected to reduce Verra Mobility's 2026 annualized revenue by $135-$145 million and EBITDA by $120-$125 million before cost cuts. This represents roughly 14% of prior 2026 revenue guidance and 30% of EBITDA guidance. The company reported $358 million in EBITDA over the last twelve months with a 57% gross profit margin.

UBS reduced its 2027-2028 EBITDA estimates by 27%-36% due to the Avis contract loss and uncertainty around renewals. Analysts cited potential pricing pressure, offset partly by cost reductions. Verra Mobility's contracts with Hertz and Enterprise are up for renewal in Q2 and Q4 2027, respectively.

Following the news, Verra Mobility revised its 2026 outlook: revenue $985-$995 million, adjusted EBITDA $380-$385 million. Multiple analysts downgraded the stock, including William Blair, Deutsche Bank, and Baird. The company is taking immediate cost-cutting steps.

More News
Yesterday / 21:01
|
861

Freedom Broker Raises Ooma Price Target to $20

Freedom Broker raises Ooma price target to $20 after strong Q1 results. Record business performance and AirDial growth drive the upgrade.

0
Yesterday / 19:30
|
571

Jefferies raises Dick's Sporting Goods target to $224

Jefferies raised its price target on Dick's Sporting Goods to $224 from $210, maintaining a Hold rating. Stock trades at $219.21.

0
Yesterday / 13:01
|
337

Morgan Stanley Backs AppLovin on Conversion Growth

Morgan Stanley reiterates Overweight on AppLovin with $720 target, highlighting conversion growth potential and strong Q1 results.

0
Yesterday / 12:31
|
689

Hershey Stock Upgraded on Confection Outlook

Evercore ISI upgrades Hershey to Outperform with a $255 price target, citing positive confection outlook and attractive valuation.

0
Yesterday / 12:31
|
281

Argus Downgrades Zoetis Stock Rating

Argus downgrades Zoetis stock to Hold on competition and margin pressure. Analyst outlook and Zoetis performance insights.

0
Yesterday / 11:04
|
827

Evercore ISI Reiterates Amphenol Outperform $180 Target

Evercore ISI reiterates Outperform rating and $180 target on Amphenol. AI revenue could exceed $9 billion by 2026.

0
Yesterday / 11:03
|
415

Okta price target raised to $110 by Cantor

Cantor Fitzgerald raised Okta price target to $110 from $100, citing workforce growth. Stock has 17% upside. Earnings due May 28.

0
Yesterday / 11:02
|
602

Oppenheimer Cuts Deere Price Target on Brazil Weakness

Oppenheimer cut Deere's price target to $680 from $715, citing Brazil agricultural weakness and tariff impacts, while maintaining an Outperform rating.

0
Yesterday / 09:33
|
700

Truist Cuts Zscaler Price Target to $200

Truist Securities cuts Zscaler price target to $200, maintains Buy rating. Conservative FY2027 outlook drives stock down 20%.

0
Yesterday / 09:32
|
715

Guggenheim Reiterates Neutral on CrowdStrike Stock

Guggenheim maintains Neutral rating on CrowdStrike (CRWD) citing valuation. Read analysis on stock performance and outlook.

0
Yesterday / 09:01
|
256

Mizuho Starts Century Therapeutics at Outperform

Mizuho initiated coverage on Century Therapeutics with an Outperform rating and $8.00 target, highlighting cell therapy for Type 1 Diabetes.

0
Yesterday / 07:32
|
969

Barclays Upgrades GXO, Raises Price Target to $65

Barclays upgrades GXO Logistics to Overweight, raising price target to $65, citing margin improvement and US expansion.

0
...